Strattera

Find out if you have a Strattera® liver claim

According to the FDA, Strattera® has been linked to liver damage side effects in two ADHD patients. The FDA has asked the manufacturer, Eli Lilly, to augment the drug's label with a bolded warning about severe liver injury. The new warning label indicates that severe liver injury may progress to liver failure resulting in death or the need for a liver transplant in a small percentage of patients.

Eli Lilly has warned doctors to stop prescribing Strattera® in patients with jaundice or existing liver damage. The updated warning and labeling follows reports of liver problems in an adult and a teenager who had been treated with Strattera for several months. According to Eli Lilly, both patients recovered after discontinuing the drug.

Strattera® is the only nonstimulant drug for attention-deficit/hyperactivity disorder. The ADHD prescription medication is also known as amoxetine HCl.

Two million people have used Strattera® since the U.S. FDA approved it in November 2002 for the treatment of attention deficit disorder in children, adolescents and adults.

If you suspect that you've experienced Strattera® side effects, you should call our lawyers now at 1-800-THE-EAGLE (1-800-843-3245) or SUBMIT A SHORT AND SIMPLE CASE FORM HERE. You may be entitled to compensation for your injuries. Contact our Strattera® lawyers today.